Codes / ICD10CM / M10.1

M10.1 Lead-induced gout

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Lead-induced gout
  • Technical Term: Lead-induced gout

Summary

Lead-induced gout is a form of arthritis caused by the deposition of urate crystals in joints, triggered by lead exposure. It occurs when lead interferes with uric acid metabolism, leading to elevated uric acid levels and crystal formation. The condition is characterized by sudden, severe joint inflammation, typically affecting the lower extremities.

Causes

Lead-induced gout results from lead exposure, which disrupts uric acid excretion by the kidneys. This disruption causes uric acid to accumulate in the blood, leading to crystal deposition in joints. Lead sources may include occupational exposure, contaminated water, or old paint.

Risk Factors

  • Occupational lead exposure (e.g., mining, battery manufacturing)
  • Environmental lead contamination (e.g., old plumbing, polluted soil)
  • Chronic lead ingestion (e.g., from lead-based paint or contaminated water)
  • Preexisting kidney dysfunction
  • High dietary purine intake
  • Male gender
  • Alcohol consumption

Symptoms

  • Sudden, intense joint pain, often in the big toe or other lower joints
  • Swelling, redness, and warmth in affected joints
  • Tenderness to touch
  • Limited range of motion
  • Possible kidney stone formation (due to lead-induced renal effects)

Diagnosis

Diagnosis involves a physical examination of affected joints, blood tests to measure uric acid and lead levels, and joint fluid analysis to detect urate crystals. Imaging studies may be used to assess joint damage. Lead exposure history is critical for confirmation.

Treatment Options

  • Chelation therapy to reduce lead levels
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation
  • Colchicine to reduce flare-ups
  • Corticosteroids for severe cases
  • Uric acid-lowering medications (e.g., allopurinol) to prevent crystal formation

Prognosis and Follow-Up

Prognosis depends on the extent of lead exposure and timely treatment. With proper lead removal and uric acid management, symptoms often improve. Regular monitoring of uric acid and kidney function is recommended to prevent recurrence or complications.

Complications

  • Chronic joint damage from repeated flare-ups
  • Kidney disease or failure due to lead toxicity
  • Hypertension
  • Neurological effects from prolonged lead exposure

Lifestyle & Prevention

  • Avoid lead exposure (e.g., use lead-free products, test water for lead)
  • Limit alcohol and purine-rich foods (e.g., red meat, seafood)
  • Stay hydrated to support uric acid excretion
  • Follow occupational safety guidelines for lead handling
  • Regular health screenings for lead exposure in high-risk groups

When to Seek Professional Help

Seek medical attention if you experience sudden joint pain, swelling, or redness, especially with a history of lead exposure. Prompt evaluation is important to prevent complications and initiate treatment.

Tips for Medical Coders

Document lead exposure history and confirmatory lab results (e.g., elevated blood lead levels) to support the diagnosis. Ensure the code M10.1 is used when lead-induced gout is the primary condition, with clear documentation linking lead exposure to the gout episode.

Book a walkthrough

M10.1 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.